FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091250587> ?p ?o ?g. }

• W2091250587 endingPage "1427.e1" @default.
• W2091250587 startingPage "1419" @default.
• W2091250587 abstract "ObjectiveTo evaluate the effects of hyperprolactinemia on the sulfated glycosaminoglycans (GAGs) of the murine uterus.DesignExperimental research.SettingUniversity biochemistry laboratory.Animal(s)Eighty female mice were divided into two groups of 40 animals each and treated with 0.2 mL of saline solution (controls, Ctr) and 200 μg of metoclopramide (experimental, HPrl). Treatments lasted for 50 consecutive days. The animals were divided into four subgroups of 10 animals each per treatment (Ctr and HPrl) and sacrificed according to the phase of the estrous cycle. The uterine horns were removed for biochemical analyses, and blood samples were collected for hormone measurements.Intervention(s)Induced hyperprolactinemia.Main Outcome Measure(s)To quantify the sulfated GAGs, and PRL and sex steroid levels.Result(s)The endometrium during the estrus phase was significantly thicker in the HPrl animals than in the Ctr mice. The levels of chondroitin and dermatan sulfate were significantly increased in the HPrl group than in the Ctr group during all phases except metestrus. The amounts of heparan sulfate were lower during estrus and diestrus and higher in the metestrus phase in HPrl than in Ctr animals. Serum PRL levels were increased whereas the levels of E2 and P were decreased in all phases in the HPrl group than in the Ctr group.Conclusion(s)The hyperprolactinemia changed the amounts of uterine sulfated GAGs. Our data suggest that these changes may not be correlated with ovarian steroid levels. To evaluate the effects of hyperprolactinemia on the sulfated glycosaminoglycans (GAGs) of the murine uterus. Experimental research. University biochemistry laboratory. Eighty female mice were divided into two groups of 40 animals each and treated with 0.2 mL of saline solution (controls, Ctr) and 200 μg of metoclopramide (experimental, HPrl). Treatments lasted for 50 consecutive days. The animals were divided into four subgroups of 10 animals each per treatment (Ctr and HPrl) and sacrificed according to the phase of the estrous cycle. The uterine horns were removed for biochemical analyses, and blood samples were collected for hormone measurements. Induced hyperprolactinemia. To quantify the sulfated GAGs, and PRL and sex steroid levels. The endometrium during the estrus phase was significantly thicker in the HPrl animals than in the Ctr mice. The levels of chondroitin and dermatan sulfate were significantly increased in the HPrl group than in the Ctr group during all phases except metestrus. The amounts of heparan sulfate were lower during estrus and diestrus and higher in the metestrus phase in HPrl than in Ctr animals. Serum PRL levels were increased whereas the levels of E2 and P were decreased in all phases in the HPrl group than in the Ctr group. The hyperprolactinemia changed the amounts of uterine sulfated GAGs. Our data suggest that these changes may not be correlated with ovarian steroid levels." @default.
• W2091250587 created "2016-06-24" @default.
• W2091250587 creator A5007392042 @default.
• W2091250587 creator A5023908527 @default.
• W2091250587 creator A5060355712 @default.
• W2091250587 creator A5063041396 @default.
• W2091250587 creator A5080186749 @default.
• W2091250587 creator A5082914808 @default.
• W2091250587 creator A5087235862 @default.
• W2091250587 creator A5088135512 @default.
• W2091250587 date "2013-11-01" @default.
• W2091250587 modified "2023-09-26" @default.
• W2091250587 title "Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle" @default.
• W2091250587 cites W1493535309 @default.
• W2091250587 cites W1967835781 @default.
• W2091250587 cites W1970706011 @default.
• W2091250587 cites W1987516422 @default.
• W2091250587 cites W1990458191 @default.
• W2091250587 cites W1997924316 @default.
• W2091250587 cites W2003520014 @default.
• W2091250587 cites W2006901889 @default.
• W2091250587 cites W2020330132 @default.
• W2091250587 cites W2025483003 @default.
• W2091250587 cites W2036170987 @default.
• W2091250587 cites W2037881342 @default.
• W2091250587 cites W2053502988 @default.
• W2091250587 cites W2063263794 @default.
• W2091250587 cites W2068223833 @default.
• W2091250587 cites W2074501002 @default.
• W2091250587 cites W2080249990 @default.
• W2091250587 cites W2086492856 @default.
• W2091250587 cites W2107283165 @default.
• W2091250587 cites W2113103296 @default.
• W2091250587 cites W2123116659 @default.
• W2091250587 cites W2140384196 @default.
• W2091250587 cites W2140566583 @default.
• W2091250587 cites W2143612388 @default.
• W2091250587 cites W2153623012 @default.
• W2091250587 cites W2154419533 @default.
• W2091250587 cites W2157531486 @default.
• W2091250587 cites W2164647225 @default.
• W2091250587 cites W2166034380 @default.
• W2091250587 cites W4256214420 @default.
• W2091250587 doi "https://doi.org/10.1016/j.fertnstert.2013.06.048" @default.
• W2091250587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23931966" @default.
• W2091250587 hasPublicationYear "2013" @default.
• W2091250587 type Work @default.
• W2091250587 sameAs 2091250587 @default.
• W2091250587 citedByCount "15" @default.
• W2091250587 countsByYear W20912505872014 @default.
• W2091250587 countsByYear W20912505872015 @default.
• W2091250587 countsByYear W20912505872016 @default.
• W2091250587 countsByYear W20912505872017 @default.
• W2091250587 countsByYear W20912505872019 @default.
• W2091250587 countsByYear W20912505872021 @default.
• W2091250587 countsByYear W20912505872022 @default.
• W2091250587 countsByYear W20912505872023 @default.
• W2091250587 crossrefType "journal-article" @default.
• W2091250587 hasAuthorship W2091250587A5007392042 @default.
• W2091250587 hasAuthorship W2091250587A5023908527 @default.
• W2091250587 hasAuthorship W2091250587A5060355712 @default.
• W2091250587 hasAuthorship W2091250587A5063041396 @default.
• W2091250587 hasAuthorship W2091250587A5080186749 @default.
• W2091250587 hasAuthorship W2091250587A5082914808 @default.
• W2091250587 hasAuthorship W2091250587A5087235862 @default.
• W2091250587 hasAuthorship W2091250587A5088135512 @default.
• W2091250587 hasBestOaLocation W20912505871 @default.
• W2091250587 hasConcept C126322002 @default.
• W2091250587 hasConcept C134018914 @default.
• W2091250587 hasConcept C143228043 @default.
• W2091250587 hasConcept C153074725 @default.
• W2091250587 hasConcept C155138218 @default.
• W2091250587 hasConcept C185592680 @default.
• W2091250587 hasConcept C1998276 @default.
• W2091250587 hasConcept C2777397205 @default.
• W2091250587 hasConcept C2778041096 @default.
• W2091250587 hasConcept C2778066728 @default.
• W2091250587 hasConcept C2778227567 @default.
• W2091250587 hasConcept C2779066055 @default.
• W2091250587 hasConcept C2779742232 @default.
• W2091250587 hasConcept C55493867 @default.
• W2091250587 hasConcept C71315377 @default.
• W2091250587 hasConcept C71924100 @default.
• W2091250587 hasConcept C86803240 @default.
• W2091250587 hasConceptScore W2091250587C126322002 @default.
• W2091250587 hasConceptScore W2091250587C134018914 @default.
• W2091250587 hasConceptScore W2091250587C143228043 @default.
• W2091250587 hasConceptScore W2091250587C153074725 @default.
• W2091250587 hasConceptScore W2091250587C155138218 @default.
• W2091250587 hasConceptScore W2091250587C185592680 @default.
• W2091250587 hasConceptScore W2091250587C1998276 @default.
• W2091250587 hasConceptScore W2091250587C2777397205 @default.
• W2091250587 hasConceptScore W2091250587C2778041096 @default.
• W2091250587 hasConceptScore W2091250587C2778066728 @default.
• W2091250587 hasConceptScore W2091250587C2778227567 @default.
• W2091250587 hasConceptScore W2091250587C2779066055 @default.
• W2091250587 hasConceptScore W2091250587C2779742232 @default.
• W2091250587 hasConceptScore W2091250587C55493867 @default.

• next